Armand, P. Et Al. 2019. Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.34 , 3291-3301.

Armand, P., Rodig, S., Melnichenko, V., Thieblemont, C., Bouabdallah, K., Tumyan, G., ... ÖZCAN, M.(2019). Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma. JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.34, 3291-3301.

Armand, Philippe Et Al. "Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma," JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.34, 3291-3301, 2019

Armand, Philippe Et Al. "Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma." JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.34, pp.3291-3301, 2019

Armand, P. Et Al. (2019) . "Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma." JOURNAL OF CLINICAL ONCOLOGY , vol.37, no.34, pp.3291-3301.

@article{article, author={Philippe Armand Et Al. }, title={Pembrolizumab in Relapsed or Refractory Primary Mediastinal Large B-Cell Lymphoma}, journal={JOURNAL OF CLINICAL ONCOLOGY}, year=2019, pages={3291-3301} }